Trends in insulin prescriptions in diabetes indicate a relevant increase in the number of insulin users among T2D patients, with around 17.4% and 52% of them, respectively, on basal-only and basal-bolus regimens [11]. The gene discussed is INS; the disease is diabetes mellitus.